Transparency Market Research Reports incorporated a definite business overview and investigation inclines on \"Anti-cancer Drugs Market\". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. \n\nRead Full Report: http://www.transparencymarketresearch.com/anticancer-drugs-market.html
Single User License:
Flat 10% Discount!!
Free Customization as per your requirement
You will get Custom Report at Syndicated Report
Report will be delivered with in 15-20 working days
Anti-cancer Drugs Market - Global
Industry Analysis, Size, Share,
Growth, Trends, and Forecast 2016 -
Transparency Market Research
90, State Street, Suite 700.
Albany, NY 12207
Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Anti-cancer
Drugs Market". This report likewise incorporates more illumination about fundamental review of the business including
definitions, requisitions and worldwide business sector industry structure.
Global Anti-cancer Drugs Market: Overview
The World Cancer Research Fund states that in 2012, there were around 14 million new cases of cancer around the world; of
these, women accounted for 6.7 million cases and men accounted for 7.4 million cases. This figure is likely to increase to 24
million by 2035. Similarly, according to the World Health Organization, an estimated 8.2 million deaths in 2012 were directly
related to cancer and the number of new cancer cases is anticipated to increase by an estimated 70% over the next two
decades. Accounting for 13% of the total number of new cases diagnosed in 2012, lung cancer was the most common cancer
across the globe, followed by breast cancer (1.7 million new cases), and colorectal cancer (1.4 million new cases).
Browse Full Report with TOC: http://www.transparencymarketresearch.com/anticancer-drugs-market.html
Cancer mortality can be reduced if the disease is detected and treated early. Timely and correct diagnosis is key to effective and
adequate treatment. Today, the global anti-cancer drugs market can be rightly characterized by the enormous amount of
innovation that hopes to transform the landscape for patients, providers, and companies alike. SEER (Surveillance,
Epidemiology, and End Results) survival statistics reveal that in 1990, only half of all cancer patients lived for five years after
diagnosis. This has now increased to two-thirds, a result of gradual but consistent innovation in the anti-cancer drugs market.
This research report serves as a blueprint for all stakeholders in the anti-cancer drugs market as it not only gives them a fresh,
objective, and accurate perspective of the global industry but also examines the key factors governing its growth from 2016 to
2024, the report’s forecast period. Leading trends, forces driving the growth, and challenges that lie ahead have been discussed
at length, supported by appropriate statistics and inputs from industry experts.
Global Anti-cancer Drugs Market: Key Trends and Opportunities
The rising global incidence of various cancers, including cancer of the breast, prostate, skin, blood, gastrointestinal tract, and
lungs, is the primary factor boosting the demand for anti-cancer drugs. In addition to this, the development of advanced
therapeutic modalities, such as targeted therapies, chemotherapy, immunotherapy, and hormonal therapies has significantly
benefited the anti-cancer drugs market in recent years.
This market is predicted to benefit from the commercialization of follow-on-biologics and patent expiration of several
blockbuster drugs. The threat of failure of the drugs, the high cost involved in the development of anti-cancer drugs, and the
possible side effects of these drugs are expected to challenge the expansion of the global market in the coming years. However,
rising government funds are likely to reduce the negative impact of these obstacles and continue propelling the anti-cancer
Global Anti-cancer Drugs Market: Competitive Landscape and Region-wise Outlook
Some of the most prominent players in the global anti-cancer drugs market are Celgene Corporation, Eli Lilly and Company,
Roche Diagnostics, Novartis AG, Pfizer, Sanofi, Amgen Inc., GlaxoSmithKline PLC, Merck & Company, and Johnson and Johnson.
Geographically, the international market for anti-cancer drugs is segmented into North America, Europe, Asia Pacific, and Rest of
the World. North America presently surpasses all of the aforementioned regional markets and is likely to retain its leading
position throughout the duration of the forecast period. Favorable reimbursement policies, the surge in investments by
prominent multinational companies in the research as well as development of anti-cancer drugs, and the high adoption rate of
immunotherapies are some of the major factors responsible for the growth of the North America anti-cancer drugs market.
Asia Pacific has been identified as a rather lucrative region for the anti-cancer drugs market owing to the rising awareness
regarding the availability of advanced therapies. The increase in healthcare expenditure and per capita disposable income is
also likely to contribute toward the future expansion of the Asia Pacific anti-cancer drugs market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and
verifiable projections about market size. The projections featured in the report have been derived using proven research
methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every
facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Download Brochure for this Report: cancer of the breast, prostate, skin, blood, gastrointestinal tract, and http://www.transparencymarketresearch.com/sample/sample.php?
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Value chain and stakeholder analysis
The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
Middle East and Africa (GCC, Southern Africa, North Africa) cancer of the breast, prostate, skin, blood, gastrointestinal tract, and
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned
analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The
report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and
market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and
mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment
over the forecast period.
Highlights of the report:
A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
Recommendations to companies for strengthening their foothold in the market
About Us cancer of the breast, prostate, skin, blood, gastrointestinal tract, and
Transparency Market Research is a market intelligence company providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and
various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most
reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
Email: [email protected]